[1]
|
Domingo, E., Martin, V., Perales, C. and Escarmis, C. (2008) Coxsackieviruses and Quasispecies Theory: Evolution of Enteroviruses. Current Topics in Microbiology and Immunology, 323, 3-32.
http://dx.doi.org/10.1007/978-3-540-75546-3_1
|
[2]
|
Chung, C.Y., Chen, C.Y., Lin, S.Y., Chung, Y.C., Chiu, H.Y., Chi, W.K., et al. (2010) Enterovirus 71 Virus-Like Particle Vaccine: Improved Production Conditions for Enhanced Yield. Vaccine, 28, 6951-6957.
http://dx.doi.org/10.1016/j.vaccine.2010.08.052
|
[3]
|
McMinn, P.C. (2012) Recent Advances in the Molecular Epidemiology and Control of Human Enterovirus 71 Infection. Current Opinion in Virology, 2, 199-205. http://dx.doi.org/10.1016/j.coviro.2012.02.009
|
[4]
|
Edlmayr, J., Niespodziana, K., Popow-Kraupp, T., Krzyzanek, V., Focke-Tejkl, M., Blaas, D., et al. (2011) Antibodies Induced with Recombinant VP1 from Human Rhinovirus Exhibit Cross-Neutralisation. European Respiratory Journal, 37, 44-52. http://dx.doi.org/10.1183/09031936.00149109
|
[5]
|
Wu, C.N., Lin, Y.C., Fann, C., Liao, N.S., Shih, S.R. and Ho, M.S. (2001) Protection against Lethal Enterovirus 71 Infection in Newborn Mice by Passive Immunization with Subunit VP1 Vaccines and Inactivated Virus. Vaccine, 20, 895-904. http://dx.doi.org/10.1016/S0264-410X(01)00385-1
|
[6]
|
DiMarchi, R., Brooke, G., Gale, C., Cracknell, V., Doel, T. and Mowat, N. (1986) Protection of Cattle against Foot-and-Mouth Disease by a Synthetic Peptide. Science, 232, 639-641. http://dx.doi.org/10.1126/science.3008333
|
[7]
|
Pfaff, E., Mussgay, M., Bohm, H.O., Schulz, G.E. and Schaller, H. (1982) Antibodies against a Preselected Peptide Recognize and Neutralize Foot and Mouth Disease Virus. EMBO Journal, 1, 869-874.
|
[8]
|
Wang, J.H., Liang, C.M., Peng, J.M., Shieh, J.J., Jong, M.H., Lin, Y.L., et al. (2003) Induction of Immunity in Swine by Purified Recombinant VP1 of Foot-and-Mouth Disease Virus. Vaccine, 21, 3721-3729.
http://dx.doi.org/10.1016/S0264-410X(03)00363-3
|
[9]
|
Domingo, E., Escarmis, C., Lazaro, E. and Manrubia, S.C. (2005) Quasispecies Dynamics and RNA Virus Extinction. Virus Research, 107, 129-139. http://dx.doi.org/10.1016/j.virusres.2004.11.003
|
[10]
|
Kawai, C. (1999) From Myocarditis to Cardiomyopathy: Mechanisms of Inflammation and Cell Death: Learning from the Past for the Future. Circulation, 99, 1091-1100. http://dx.doi.org/10.1161/01.CIR.99.8.1091
|
[11]
|
Zhang, L., Parham, N.J., Zhang, F., Aasa-Chapman, M., Gould, E.A. and Zhang, H. (2012) Vaccination with Coxsackievirus B3 Virus-Like Particles Elicits Humoral Immune Response and Protects Mice against Myocarditis. Vaccine, 30, 2301-2308. http://dx.doi.org/10.1016/j.vaccine.2012.01.061
|
[12]
|
Henke, A., Wagner, E., Whitton, J.L., Zell, R. and Stelzner, A. (1998) Protection of Mice against Lethal Coxsackievirus B3 Infection by Using DNA Immunization. Journal of Virology, 72, 8327-8331.
|
[13]
|
Henke, A., Zell, R. and Stelzner, A. (2001) DNA Vaccine-Mediated Immune Responses in Coxsackie Virus B3-In- fected Mice. Antiviral Research, 49, 49-54. http://dx.doi.org/10.1016/S0166-3542(00)00132-7
|
[14]
|
Kim, J.Y., Jeon, E.S., Lim, B.K., Kim, S.M., Chung, S.K., Kim, J.M., et al. (2005) Immunogenicity of a DNA Vaccine for Coxsackievirus B3 in Mice: Protective Effects of Capsid Proteins against Viral Challenge. Vaccine, 23, 1672-1679.
http://dx.doi.org/10.1016/j.vaccine.2004.10.008
|
[15]
|
Fechner, H., Sipo, I., Westermann, D., Pinkert, S., Wang, X., Suckau, L., et al. (2008) Cardiac-Targeted RNA Interference Mediated by an AAV9 Vector Improves Cardiac Function in Coxsackievirus B3 Cardiomyopathy. Journal of Molecular Medicine, 86, 987-997. http://dx.doi.org/10.1007/s00109-008-0363-x
|
[16]
|
Watanabe, R., Hasegawa, A., Miyazawa, T., Kato, H. and Iwata, H. (2004) Generation of Monoclonal Antibodies to Porcine Interleukin 6 (PIL-6) Using the Recombinant PIL-6 Expressed in Escherichia coli. Journal of Veterinary Medical Science, 66, 1053-1057. http://dx.doi.org/10.1292/jvms.66.1053
|
[17]
|
Lindberg, A.M., Stalhandske, P.O. and Pettersson, U. (1987) Genome of Coxsackievirus B3. Virology, 156, 50-63.
http://dx.doi.org/10.1016/0042-6822(87)90435-1
|
[18]
|
Lindberg, A.M., Crowell, R.L., Zell, R., Kandolf, R. and Pettersson, U. (1992) Mapping of the RD Phenotype of the Nancy Strain of Coxsackievirus B3. Virus Research, 24, 187-196. http://dx.doi.org/10.1016/0168-1702(92)90006-U
|
[19]
|
Pfaff, E., Thiel, H.J., Beck, E., Strohmaier, K. and Schaller, H. (1988) Analysis of Neutralizing Epitopes on Foot-and-Mouth Disease Virus. Journal of Virology, 62, 2033-2040.
|
[20]
|
Beatrice, S.T., Katze, M.G., Zajac, B.A. and Crowell, R.L. (1980) Induction of Neutralizing Antibodies by the Coxsackievirus B3 Virion Polypeptide, VP2. Virology, 104, 426-438. http://dx.doi.org/10.1016/0042-6822(80)90345-1
|
[21]
|
Strebel, K., Beck, E., Strohmaier, K. and Schaller, H. (1986) Characterization of Foot-and-Mouth Disease Virus Gene Products with Antisera against Bacterially Synthesized Fusion Proteins. Journal of Virology, 57, 983-991.
|
[22]
|
Strohmaier, K., Franze, R. and Adam, K.H. (1982) Location and Characterization of the Antigenic Portion of the FMDV Immunizing Protein. Journal of General Virology, 59, 295-306. http://dx.doi.org/10.1099/0022-1317-59-2-295
|
[23]
|
Lee, C.D., Yan, Y.P., Liang, S.M. and Wang, T.F. (2009) Production of FMDV Virus-Like Particles by a SUMO Fusion Protein Approach in Escherichia coli. Journal of Biomedical Science, 16, 69.
http://dx.doi.org/10.1186/1423-0127-16-69
|
[24]
|
Page, G.S., Mosser, A.G., Hogle, J.M., Filman, D.J., Rueckert, R.R. and Chow, M. (1988) Three-Dimensional Structure of Poliovirus Serotype 1 Neutralizing Determinants. Journal of Virology, 62, 1781-1794.
|
[25]
|
Liew, M.W., Rajendran, A. and Middelberg, A.P. (2010) Microbial Production of Virus-Like Particle Vaccine Protein at Gram-Per-Litre Levels. Journal of Biotechnology, 150, 224-231. http://dx.doi.org/10.1016/j.jbiotec.2010.08.010
|
[26]
|
Getts, M.T., Richards, M.H. and Miller, S.D. (2010) A Critical Role for Virus-Specific CD8+ CTLs in Protection from Theiler’s Virus-Induced Demyelination in Disease-Susceptible SJL Mice. Virology, 402, 102-111.
http://dx.doi.org/10.1016/j.virol.2010.02.031
|